NEW YORK (GenomeWeb News) — Waters and Advion Biosciences have completed the evaluation phase of a product-integration effort and have kicked off a co-marketing campaign this week at the LC-MS Montreux Symposium in Switzerland, Waters said.
The companies are integrating Advion’s TriVersa NanoMate infusion technology with Waters’ Synapt high definition mass spectrometer into a platform that Waters said will help researchers maximize the information they can pull from large quantities of samples.
An Advion spokesperson said the products will be interoperable in three to six months.
Waters’ Synapt can probe the size and shape of ions, while Advion’s NanoMate makes it easier to maintain the “native conformation of protein or peptide ions into the gas phase,” which the company said also increases reproducibility.
Waters said the integrated product will be used to “analyze monoclonal antibodies, multi-protein and protein-ligand complexes, top down proteomics and metabolite identification."